Cargando…
Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients
OBJECTIVE: To prolong the health expectancy, it is important to prevent age-related diseases, such as osteoporosis and cerebrovascular disease, which are major causes of a bedridden state. Early predictable biomarkers for these diseases are urgently required in the clinical setting. Three members of...
Autores principales: | Yamamoto, Shogo, Koyama, Daisuke, Igarashi, Ryo, Maki, Takumi, Mizuno, Hiroyuki, Furukawa, Yusuke, Kuro-o, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028420/ https://www.ncbi.nlm.nih.gov/pubmed/32009088 http://dx.doi.org/10.2169/internalmedicine.3597-19 |
Ejemplares similares
-
The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease
por: Yamada, Hodaka, et al.
Publicado: (2016) -
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
por: Shimizu, Makoto, et al.
Publicado: (2022) -
Calciprotein particles and fibroblast growth factor 23 contribute to the pathophysiology of hypercalcemia in a patient with renal sarcoidosis
por: Iwazu, Yoshitaka, et al.
Publicado: (2019) -
New endoscopic ultrasonography criteria for malignant lymphadenopathy based on inter-rater agreement
por: Takasaki, Yusuke, et al.
Publicado: (2019) -
The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio, Deemed the Nephron Index, Is a Useful Clinical Index for Early Stage Chronic Kidney Disease in Patients with Type 2 Diabetes: An Observational Pilot Study
por: Yamada, Hodaka, et al.
Publicado: (2018)